Skip to main content
Fig. 4 | Journal of Experimental & Clinical Cancer Research

Fig. 4

From: JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors

Fig. 4

Immune and genetic profiles of high pSTAT3 expression within TSPhigh cases. Box plot showing association between CD45Ro + (A), CD3 + (B), CD8 + (C), FOXP3 + (D), CD66b + (E), CD68 + (F), CD80 + (G), PDL1 + (H), PD1 + (I) and Ki67 + cells (J) and pSTAT3tyr705 status within TSPhigh tumors. Statistical significance was assessed using Mann–Whitney tests and bars represent mean ± standard error of the mean. Corrplot showing the association between pSTAT3 status and clinicopathological characteristics of TSPhigh patients (K). Oncoplot showing the top mutated genes between high and low pSTAT3tyr705 groups within the TSPhigh patients (L). Enrichment plots showing the key pathways upregulated in pSTAT3tyr705 high TSPhigh tumors (M–N). Kaplan Meier survival curve showing the association between pSTAT3tyr705 and TSP score in cohort 3 (p = 0.0019) (O). Volcano plot showing differential gene expression analysis of high versus low pSTAT3tyr705 within TSPhigh cases (P). Box plots showing top upregulated and downregulated genes across pSTAT3tyr705 high and low groups within TSPhigh tumors of cohort 3 (Q). Significance set to p < 0.05*, p < 0.005**, p < 0.0005***, p < 0.00005****

Back to article page